Novo Nordisk A/S (NYSE:NVO)

50.99
Delayed Data
As of Feb 20
 -0.87 / -1.68%
Today’s Change
32.89
Today|||52-Week Range
58.37
-4.99%
Year-to-Date

Today’s Trading

Previous close51.86
Today’s open51.23
Day’s range50.90 - 51.54
Volume1,664,072
Average volume (3 months)1,650,555
Market cap$102.0B
Data as of 4:02pm ET, 02/20/2018

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+3.81%
P/E ratio19.9
Price/Sales5.48
Price/Book20.23

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-1.42-1.80%
ABTAbbott Laboratories-1.05-1.75%
GSKGlaxoSmithKline-0.37-0.98%
BMYBristol-Myers Squibb-1.61-2.33%
Data as of 4:02pm ET, 02/20/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)$0.69
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts